Adhesives Research Ireland Ltd. of Limerick at COMPAMED 2018 in Düsseldorf -- MEDICA - World Forum for Medicine

Adhesives Research Ireland Ltd.

Raheen Business Park, Raheen, V94 VH22 Limerick
Telephone +353 61 300300
Fax +353 61 480456

Hall map

COMPAMED 2018 hall map (Hall 8a): stand M32

Fairground map

COMPAMED 2018 fairground map: Hall 8a

Our range of products

Product categories

  • 01  Manufacturing of components
  • 01.09  Other component manufacturing

Other component manufacturing

  • 08  Raw materials, materials, adhesives
  • 08.07  Packaging materials

Packaging materials

  • 08  Raw materials, materials, adhesives
  • 08.08  Adhesives


  • 08  Raw materials, materials, adhesives
  • 08.09  Other raw materials, materials, adhesives

Our products

Product category: Other raw materials, materials, adhesives

ARx Oral Thin Films (OTFs)

ARx, LLC custom develops and formulates drug-loaded oral thin film (OTF) polymer coatings designed to erode/dissolve at pre-determined rates when introduced to saliva for absorption in the gastrointestinal (GI) tract. OTFs are a beneficial means for administering treatments and improving compliance in pediatric, geriatric, veterinary and compromised patient populations.

Oral thin films can integrate most available forms of active pharmaceutical ingredients (APIs), including micronized, granulated, salt and free-base forms. Both soluble and insoluble drugs have been successfully compounded into solutions and suspensions which can be further processed into a dissolvable film. The intended dose is achieved by determining and precisely controlling the size and thickness of the final film.

Benefits of ARx oral thin film technologies:

Formulation Flexibility:

  • Tailorable film characteristics including dissolution rates, film thickness, material composition and taste-masking
  • Dissolution may be triggered for a specific biological fluid, pH or other condition
  • Multi-layered product constructions available for optimum bio-availability and stability
  • A variety of excipient options for API compatibility and stability
  • Novel dosage format for product line extension
  • Delivery of stable drug compounds and GRAS ingredients through excipient selection and product design
Patient Convenience:
  • Eliminates need for water or utensils to administer and swallow
  • Discrete, easy to transport and administer
  • Comfortable and discrete during dosing
  • Pleasant taste and mouth feel
Drug Delivery Benefits:
  • Systemic drug delivery through absorption in the GI tract
  • Enables small molecule GI delivery
  • Rapid disintegration tailored for fast onset

More Less

Product category: Other raw materials, materials, adhesives

ARx Transdermal Drug-in-Adhesive Systems

ARx, LLC custom develops and manufactures patches for transdermal drug delivery in support of both branded and generic applications. Leveraging over 30 years of transdermal adhesive expertise, excipients are carefully selected to assure patient comfort during wear and to achieve the intended drug delivery profile. Material selection is further complimented by options for chemically-compatible release liners to complete the product construction. Formulation scientists carefully design both single and multi-layered patches for specialized drug delivery up to 7 days.

Benefits of ARx transdermal drug-in-adhesive systems:

Formulation Flexibility:
  • Tailored adhesive formulations in a range of chemistries and product constructions for prescribed wear times up to 7 days
  • Ultra-clean adhesive and excipient selection for non-interference with API
  • Tight thickness control in processing
  • Use of single & multi-layered systems, enhancers and rate controlling membranes targeted drug delivery
Patient Convenience:
  • Discrete, easy to transport and administer
  • Comfortable and discrete during dosing
  • Minimizes number of product applications through extended wear
  • Improved market success through enhanced compliance
  • Selection of biocompatible, non-cytotoxic, non-irritating or sensitizing raw materials
Drug Delivery Benefits:
  • Systemic drug delivery
  • Bypass first metabolism effect
  • Bypass enzymatic degradation
  • Controlled release from several hours to 7 days
  • Immediate cessation to dosing by patch removal

More Less

About us

Company details

Adhesives Research, Inc. (AR) is a leading independent developer and manufacturer of pressure-sensitive adhesives (PSAs), polymers, tapes, films, coatings, laminates, release liners and drug delivery systems.

We are committed to being the most effective company in our field by:
  • Partnering with our customers
  • Developing and manufacturing the specialized products our customers seek for improving their product.
Established in 1961, AR’s humble beginnings originated in a converted garage to develop and supply specialty adhesive-coated materials and processing equipment to meet the evolving needs of the graphics arts label market.

Through several moves and expansions, AR grew steadily, developing new capabilities and technologies that enabled the company to address the unmet needs of new markets. Rapid growth led to facility expansions to include the U.S., South America (1980), Europe (1999) and Asia (2000). With headquarters in Glen Rock, PA and Limerick, Ireland, today the company’s facilities span over 250 acres, cover over 300,000+ square feet of development and manufacturing space and employ approximately 300 associates.

Adhesives Research, Inc. is organized into two unique businesses:
  • Adhesives Research supplies high-performance specialty films, PSAs, tapes, coatings, films, laminates and components to the medical, pharmaceutical, electronics, industrial, and splicing markets
  • ARx, LLC, a wholly-owned subsidiary, develops and manufactures client-specific transdermal and thin film drug delivery systems with pharmaceutical and biotech partners.
During the past 50+ years, AR has emerged as a leader in our field through the continuous development of core technologies and capabilities. Today we remain an independent company, committed to working with customers as our partners in the development of application-specific products that fill their unmet material needs.

More Less